New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 21, 2014
08:38 EDTROSGRosetta Genomics announces its cancer test received provider status
Rosetta Genomics announces the Rosetta Cancer Origin Test has received in-network provider status with Highmark Health Services, a subsidiary of Highmark. This test for the identification of the tumor origin in Cancer of Unknown or Uncertain Primary is now available to eligible Highmark Health Services members as an in-network service based on the individual member's benefits.
News For ROSG From The Last 14 Days
Check below for free stories on ROSG the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 4, 2014
08:20 EDTROSGRosetta Genomics to receive U.S. patent for cancer origin assay
Rosetta Genomics announced that the company received a Notice of Allowance from the United States Patent and Trademark Office for a patent covering the method of use of a core element of Rosetta Genomics' microRNA technology in the identification of the tumor of origin in cancer of unknown or uncertain primary and metastatic cancer. The issued claims for U.S. Patent Application No. 13/167,489 is entitled "Gene Expression Signature for Classification of Tissue of Origin of Tumor Samples."

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use